We Just Had An Epiphany
Tag: contrarian investing
Year-Old CEO Could Start Making an Impact: Can Teladoc (TDOC) Reboot Growth, Turn a Profit, and Send Its Stock Back to the Moon?
Teladoc Health is down 97% from ATH — but Citron says Livongo is booming, institutions are buying, and the CEO just hit his one-year mark. Bargain bin or value trap?